1-acetyl-3,2-toluyl-5-fluorouracil has been researched along with Cancer of Stomach in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MH; Cui, SX; Gai, RY; Liu, J; Makuuchi, M; Qu, XJ; Tang, W; Wang, RH; Xu, WF; Yuan, YX; Zhou, Y | 1 |
| Chen, MH; Cheng, YN; Cui, SX; Li, X; Liu, J; Makuuchi, M; Qu, XJ; Tang, W; Tian, ZG; Xu, WF | 1 |
2 other study(ies) available for 1-acetyl-3,2-toluyl-5-fluorouracil and Cancer of Stomach
| Article | Year |
|---|---|
Inhibition of human gastric carcinoma cell growth by atofluding derivative N3-o-toluyl-fluorouracil.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Liver; Male; Mice; Mice, Nude; Rats; Rats, Sprague-Dawley; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2006 |
Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; In Situ Nick-End Labeling; Mice; Mice, Nude; Microsomes, Liver; Prodrugs; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2007 |